CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma

Leukemia Research

Volumn 34, Issue 9, 2010, Pages 1235-1238

  Jevremovic, Dragan ^a   Dronca, Roxana S ^a   Morice, William G ^a   McPhail, Ellen D ^a   Kurtin, Paul J ^a   Zent, Clive S ^a   Hanson, Curtis A ^a  

^a MAYO CLINIC   (United States)

Author keywords

CD5 positive; Chronic lymphocytic leukemia; Chronic lymphoproliferative disorders; Flow cytometry

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M;

ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOPLASMACYTIC LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NODAL MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; SPLENIC MARGINAL ZONE LYMPHOMA;

EID: 77955251533     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.03.020     Document Type: Article

References (9)

1. Cro L., et al. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias. Leukemia 2003, 17(1):125-132.
2. Carsetti R., Rosado M.M., Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004, 197:179-191.
3. Gary-Gouy H., et al. The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem 2000, 275(1):548-556.
4. Gary-Gouy H., et al. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002, 100(13):4537-4543.
5. Morice W.G., et al. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin Proc 2008, 83(7):776-785.
6. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2008 2008, IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stain, J. Thiele, J.W. Vardiman (Eds.).
7. Matutes E., et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994, 8(10):1640-1645.
8. Giannouli S., et al. Splenic marginal zone lymphomas with peripheral CD5 expression. Haematologica 2004, 89(1):113-114.
9. Baseggio L., et al. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathologic, cytogenetic and molecular study of 24 cases. Haematologica 2009.